Equity Details
Price & Market Data
Price: $1.59
Daily Change: +$0.016 / 1.01%
Daily Range: $1.53 - $1.60
Market Cap: $114,233,120
Daily Volume: 585,138
Performance Metrics
1 Week: 3.95%
1 Month: -15.96%
3 Months: 17.04%
6 Months: 15.33%
1 Year: -10.73%
YTD: 27.42%
About Biomea Fusion, Inc. (BMEA)
Financial summary for Biomea Fusion, Inc. (BMEA). Price: 1.59, daily change: +$0.016 / 1.01%. Market cap: 114,233,120. Performance for all periods at a glance.
Company Details
Employees: 41
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Biomea Fusion, Inc., a clinical-stage diabetes and obesity medicines company, focuses on the discovery and development of oral covalent small molecule drugs to treat patients with metabolic diseases in the United States. It's lead product candidate icovamenib, an orally bioavailable, potent, and covalent inhibitor of menin, a ubiquitously expressed scaffold protein that functions in histone modification and epigenetic gene regulation to impact multiple cellular processes including cell cycle control, apoptosis, and DNA damage repair. Biomea Fusion, Inc. was incorporated in 2017 and is headquartered in San Carlos, California.